Ongoing protocols for non-AIDS primary central nervous system lymphoma

Journal of Neuro-Oncology

Volumn 43, Issue 3, 1999, Pages 287-291

  Hoang Xuan, Khê ^a   Delattre, Jean Yves ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Chemotherapy; Primary central nervous system lymphoma; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; HYDROCORTISONE; METHOTREXATE; PROCARBAZINE; VINCRISTINE;

AGE; CENTRAL NERVOUS SYSTEM DISEASE; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; REVIEW;

CENTRAL NERVOUS SYSTEM NEOPLASMS; CLINICAL PROTOCOLS; CLINICAL TRIALS; HUMANS; LYMPHOMA, NON-HODGKIN; MULTICENTER STUDIES;

EID: 0032832009     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006266821574     Document Type: Review

References (20)

1. Fine HA, Mayer RJ: Primary central nervous system lymphoma. Ann Intern Med 119: 1093-1104, 1993
2. De Angelis L: Current management of primary central nervous system lymphoma. Oncology 9: 63-76, 1995
3. Reni M, Ferreri AJM, Garancini MP, Villa E: Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature. Ann Oncol 8: 227-234, 1997
4. Dahlborg SA, Henner WD, Crossen JR, Tableman M, Petrillo A, Braziel R, Neuwelt EA: Non AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy. Cancer J Sci Am 2: 166-174, 1996
5. Cher L, Glass J, Harsh GR, Hochberg F: Therapy of primary CNS lymphoma with Methotrexate-based chemotherapy and deferred radiotherapy: preliminary results. Neurology 46: 1757-1759, 1996
6. Freilich RJ, Delattre JY, Monjour A, De Angelis L: Chemotherapy without radiation therapy as initial treatment for primary cerebral lymphoma in older patients. Neurology 46: 435-440, 1996
7. Hoang-Xuan K, Chinot O, Frenay M, Taillandier L, Hildebrand J, Monjour A, Van den Bent M, Sahmoud T, Poisson M, Delattre JY: Chemotherapy alone as initial treatment of primary central nervous system lymphoma in older patients (abstract). Neurology 48: A17, 1997
8. Bessel EM, Graus F, Punt JAG, Firth JL, Hope DT, Moloney AJ, Lopez-Guillermo A, Villa S: Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy. J Clin Oncol 14: 945-954, 1996
9. De Angelis L, Yahalom J, Thaler HT, Kher U: Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10: 635-643, 1992
10. Desablens B, François S, Rodier JM, Le Mevel A, Delwail V, Sensebe L, Le Prise PY, Colombat P, Deconinck E, Brière J, Harousseau JL, Bauduer F, Lamour C: Prognostic factors in HIV negative primary CNS NHL. Analysis from 135 patients treated by the LCP88 trial (abstract). Blood 90 (suppl 1): 587, 1997
11. Blay JY, Bouhour D, Carrie C, Bouffet E, Brunat-Mentigny M, Philip T, Biron P: The C5R protocol: a regimen of high dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression. Blood 86: 2922-2929, 1995
12. Vigliani MC, Delattre JY: Radiation induced intellectual deterioration in adults: a review. Handbook of Clinical Neurology 24: 68, 1998 (in press)
13. Nelson DF, Martz K, Bonner H, Nelson JS, Newall J, Kerman HD, Thomson JW, Murray KJ: Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Rad Oncol Biol Phys 23: 9-17, 1992
14. Gabbai A, Hochberg FH, Lindgood RM, Bashir R, Hotleman K: High dose methotrexate for non AIDS primary CNS lymphoma. J Neurosurg 70: 190-194, 1989
15. Neuwelt EA, Goldman DL, Dahlborg SA, Crossen J, Ramsey F, Roman-goldstein S, Braziel R, Dana B: Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive functions. J Clin Oncol 9: 1580-1590, 1991
16. Glass J, Gruber ML, Cher L, Hochberg FH: Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long term outcome. J Neurosurg 81: 188-195, 1994
17. Glass J, Shustik C, Hochberg FH, Cher L, Gruber ML: Therapy of primary central nervous system lymphoma with preirradiation methotrexate, cyclophosphamide, doxorubicin, vincristine, and dexamethasone (MCHOD). J Neuro-Oncol 30: 257-265, 1996
18. Sarazin M, Ameri A, Monjour A, Nibio A, Poisson M, Delattre JY: Primary CNS lymphoma: treatment with chemotherapy and radiotherapy. Eur J Cancer 31A: 2003-2007, 1996
19. Hoang-Xuan K, Taillandier L, Chinot O, Frenay M, Hildebrand J, Monjour A, Broët R Poisson M, DePathe J̇Y: Chemotherapy alone for primary CNS lymphoma in young patients (abstract). Neurology 50 (suppl 4): 353, 1998
20. Soussain C, Hoang-Xuan K, Azar N, Suzan F, Gerber S, DePathe J̇Y: Pilot study of intensive chemotherapy followed by hematopoietic stem cell rescue in patients with refractory or relapsed primary CNS lymphoma or intra-ocular lymphoma (abstract). Neurology 52 (suppl 2): 246, 1999